AAAAAA

   
Results: 1-25 | 26-50 |
Results: 26-50/50
TECHNIQUES FOR PREOPERATIVE MARKING OF NON-PALPABLE LESIONS OF THE BREAST IN MR TOMOGRAPHY
Authors: SITTEK H KESSLER M MULLERLISSE U UNTCH M BOHMERT H REISER M
Citation: H. Sittek et al., TECHNIQUES FOR PREOPERATIVE MARKING OF NON-PALPABLE LESIONS OF THE BREAST IN MR TOMOGRAPHY, RoFo. Fortschritte auf dem Gebiete der Rontgenstrahlen und der neuenbildgebenden Verfahren, 165(1), 1996, pp. 84-87
INTERIM ANALYSIS OF A PHASE-II STUDY OF EPIRUBICIN AND PACLITAXEL AS FIRST-LINE THERAPY IN PATIENTS WITH METASTATIC BREAST-CANCER
Authors: LUCK HJ THOMSSEN C DUBOIS A LISBOA BW UNTCH M KUHNLE H KONECNY G JANICKE F MEERPOHL HG LINDNER C HECKER D DIERGARTEN K
Citation: Hj. Luck et al., INTERIM ANALYSIS OF A PHASE-II STUDY OF EPIRUBICIN AND PACLITAXEL AS FIRST-LINE THERAPY IN PATIENTS WITH METASTATIC BREAST-CANCER, Seminars in oncology, 23(1), 1996, pp. 33-36
MR-IMAGING OF THE BREAST - LOCALIZATION OF FOCAL BREAST-LESIONS THAT ARE UNDETECTABLE WITH MAMMOGRAPHY OR US
Authors: SITTEK H KESSLER M MUELLERLISSE UG HEUCK AF UNTCH M BECKER CR
Citation: H. Sittek et al., MR-IMAGING OF THE BREAST - LOCALIZATION OF FOCAL BREAST-LESIONS THAT ARE UNDETECTABLE WITH MAMMOGRAPHY OR US, Radiology, 201, 1996, pp. 1194-1194
COMPARATIVE ANALYSES OF BONE-MARROW MICROMETASTASES IN BREAST AND GASTRIC-CANCER
Authors: FUNKE I FRIES S ROLLE M HEISS MM UNTCH M BOHMERT H SCHILDBERG FW JAUCH KW
Citation: I. Funke et al., COMPARATIVE ANALYSES OF BONE-MARROW MICROMETASTASES IN BREAST AND GASTRIC-CANCER, International journal of cancer, 65(6), 1996, pp. 755-761
TUMOR CHEMOSENSITIVITY AND CHEMORESISTANCE ASSAYS
Authors: CREE LA PETTY RD KURBACHER CM UNTCH M
Citation: La. Cree et al., TUMOR CHEMOSENSITIVITY AND CHEMORESISTANCE ASSAYS, Cancer, 78(9), 1996, pp. 2031-2032
EFFECT OF INTERFERONS ON HORMONE-RECEPTOR LEVELS OF ENDOMETRIAL CANCER-CELLS
Authors: ANGIOLI R SEVIN BU UNTCH M KOECHLI OR RODRIGUEZ M PERRAS JP AVERETTE HE
Citation: R. Angioli et al., EFFECT OF INTERFERONS ON HORMONE-RECEPTOR LEVELS OF ENDOMETRIAL CANCER-CELLS, Oncology Reports, 2(2), 1995, pp. 285-288
SYNERGISTIC EFFECT OF DELTA-AMINOLEVULINI C-ACID AND PHOTODYNAMIC LASER THERAPY IN-VITRO WITH THE ATP TUMORCHEMOSENSITIVITY ASSAY
Authors: UNTCH M KORELL M KIRSCHSTEIN M HEPP H
Citation: M. Untch et al., SYNERGISTIC EFFECT OF DELTA-AMINOLEVULINI C-ACID AND PHOTODYNAMIC LASER THERAPY IN-VITRO WITH THE ATP TUMORCHEMOSENSITIVITY ASSAY, Gynakologisch-geburtshilfliche Rundschau, 35(2), 1995, pp. 85-89
PHOTODYNAMIC LASER THERAPY IN GYNECOLOGY
Authors: KORELL M UNTCH M ABELS C DELLIAN M KIRSCHSTEIN M BAUMGARTNER R BEYER W GOETZ AE
Citation: M. Korell et al., PHOTODYNAMIC LASER THERAPY IN GYNECOLOGY, Gynakologisch-geburtshilfliche Rundschau, 35(2), 1995, pp. 90-97
DETECTION OF TUMOR-CELLS IN THE BONE-MARROW OF BREAST-CANCER PATIENTSBY CYTOKERATIN-19 - REVERSE-TRANSCRIPTASE - POLYMERASE CHAIN-REACTION(RT-PCR)
Authors: NESTLEKRAMLING C UNTCH M HAGEN D FIELDS K FUNKE I KONECNY G
Citation: C. Nestlekramling et al., DETECTION OF TUMOR-CELLS IN THE BONE-MARROW OF BREAST-CANCER PATIENTSBY CYTOKERATIN-19 - REVERSE-TRANSCRIPTASE - POLYMERASE CHAIN-REACTION(RT-PCR), European journal of cancer, 31A, 1995, pp. 74-74
ADJUVANT HIGH-DOSE EPIRUBICIN AND CYCLOPHOSPHAMIDE WITH G-CSF SUPPORTIN PATIENTS WITH LOCALLY ADVANCED BREAST-CANCER
Authors: KONECNY G UNTCH M BAUERFEIND I PICHE E NESTLEKRAMLING C
Citation: G. Konecny et al., ADJUVANT HIGH-DOSE EPIRUBICIN AND CYCLOPHOSPHAMIDE WITH G-CSF SUPPORTIN PATIENTS WITH LOCALLY ADVANCED BREAST-CANCER, European journal of cancer, 31A, 1995, pp. 79-79
IN-VITRO CHEMOSENSITIVITY OF PACLITAXEL AND OTHER CHEMOTHERAPEUTIC-AGENTS IN MALIGNANT GESTATIONAL TROPHOBLASTIC NEOPLASMS
Authors: KOECHLI OR SCHAER GN SEVIN BU PERRAS JP SCHENK V RODRIGUEZ M UNTCH M STEREN A HALLER U
Citation: Or. Koechli et al., IN-VITRO CHEMOSENSITIVITY OF PACLITAXEL AND OTHER CHEMOTHERAPEUTIC-AGENTS IN MALIGNANT GESTATIONAL TROPHOBLASTIC NEOPLASMS, Anti-cancer drugs, 6(1), 1995, pp. 94-100
DNA CELL-CYCLE ANALYSIS OF CERVICAL-CANCER BY FLOW-CYTOMETRY USING SIMULTANEOUS CYTOKERATIN LABELING FOR IDENTIFICATION OF TUMOR-CELLS
Authors: KIMMIG R KAPSNER T SPELSBERG H UNTCH M HEPP H
Citation: R. Kimmig et al., DNA CELL-CYCLE ANALYSIS OF CERVICAL-CANCER BY FLOW-CYTOMETRY USING SIMULTANEOUS CYTOKERATIN LABELING FOR IDENTIFICATION OF TUMOR-CELLS, Journal of cancer research and clinical oncology, 121(2), 1995, pp. 107-114
CHEMOSENSITIVITY TESTING OF HUMAN TUMORS USING A MICROPLATE ADENOSINE-TRIPHOSPHATE LUMINESCENCE ASSAY - CLINICAL CORRELATION FOR CISPLATIN RESISTANCE OF OVARIAN-CARCINOMA
Authors: ANDREOTTI PE CREE IA KURBACHER CM HARTMANN DM LINDER D HAREL G GLEIBERMAN I CARUSO PA RICKS SH UNTCH M SARTORI C BRUCKNER HW
Citation: Pe. Andreotti et al., CHEMOSENSITIVITY TESTING OF HUMAN TUMORS USING A MICROPLATE ADENOSINE-TRIPHOSPHATE LUMINESCENCE ASSAY - CLINICAL CORRELATION FOR CISPLATIN RESISTANCE OF OVARIAN-CARCINOMA, Cancer research, 55(22), 1995, pp. 5276-5282
COMPARISON OF PACLITAXEL AND DOCETAXEL (TAXOTERE) IN GYNECOLOGIC AND BREAST-CANCER CELL-LINES WITH THE ATP-CELL VIABILITY ASSAY
Authors: UNTCH M UNTCH A SEVIN BU ANGIOLI R PERRAS JP KOECHLI O AVERETTE HE
Citation: M. Untch et al., COMPARISON OF PACLITAXEL AND DOCETAXEL (TAXOTERE) IN GYNECOLOGIC AND BREAST-CANCER CELL-LINES WITH THE ATP-CELL VIABILITY ASSAY, Anti-cancer drugs, 5(1), 1994, pp. 24-30
FLOW CYTOMETRIC DNA ANALYSIS OF BREAST-CANCER BY 2 COLOR METHOD USINGCYTOKERATIN LABELING FOR IDENTIFICATION OF TUMOR-CELLS
Authors: KIMMIG R SPELSBERG H KAPSNER T UNTCH M HEPP H
Citation: R. Kimmig et al., FLOW CYTOMETRIC DNA ANALYSIS OF BREAST-CANCER BY 2 COLOR METHOD USINGCYTOKERATIN LABELING FOR IDENTIFICATION OF TUMOR-CELLS, Analytical cellular pathology, 7(3), 1994, pp. 205-215
EVALUATION OF PACLITAXEL (TAXOL), CISPLATIN, AND THE COMBINATION PACLITAXEL-CISPLATIN IN OVARIAN-CANCER IN-VITRO WITH THE ATP CELL VIABILITY ASSAY
Authors: UNTCH M SEVIN BU PERRAS JP ANGIOLI R UNTCH A HIGHTOWER RD KOECHLI O AVERETTE HE
Citation: M. Untch et al., EVALUATION OF PACLITAXEL (TAXOL), CISPLATIN, AND THE COMBINATION PACLITAXEL-CISPLATIN IN OVARIAN-CANCER IN-VITRO WITH THE ATP CELL VIABILITY ASSAY, Gynecologic oncology, 53(1), 1994, pp. 44-49
CONTRAST-ENHANCED MR-IMAGING OF THE BREAST - COMPARISON OF 2 DIFFERENT DOSES OF GADOPENTETATE DIMEGLUMINE
Authors: HEYWANGKOBRUNNER SH HAUSTEIN J POHL C BECK R LOMMATZSCH B UNTCH M NATHRATH WBJ
Citation: Sh. Heywangkobrunner et al., CONTRAST-ENHANCED MR-IMAGING OF THE BREAST - COMPARISON OF 2 DIFFERENT DOSES OF GADOPENTETATE DIMEGLUMINE, Radiology, 191(3), 1994, pp. 639-646
COMPARATIVE CHEMOSENSITIVITY PROFILES IN 3 HUMAN BREAST-CANCER CELL-LINES WITH THE ATP-CELL VIABILITY ASSAY
Authors: KOECHLI OR SEVIN BU PERRAS JP ANGIOLI R UNTCH M STEREN A RAMACHANDRAN C AVERETTE HE
Citation: Or. Koechli et al., COMPARATIVE CHEMOSENSITIVITY PROFILES IN 3 HUMAN BREAST-CANCER CELL-LINES WITH THE ATP-CELL VIABILITY ASSAY, Oncology, 51(6), 1994, pp. 552-558
TUMOR-CELL DETECTION IN THE BONE-MARROW OF BREAST-CANCER PATIENTS AT PRIMARY THERAPY - RESULTS OF A 3-YEAR MEDIAN FOLLOW-UP
Authors: HARBECK N UNTCH M PACHE L EIERMANN W
Citation: N. Harbeck et al., TUMOR-CELL DETECTION IN THE BONE-MARROW OF BREAST-CANCER PATIENTS AT PRIMARY THERAPY - RESULTS OF A 3-YEAR MEDIAN FOLLOW-UP, British Journal of Cancer, 69(3), 1994, pp. 566-571
INVITRO EVALUATION OF THE NOVEL CHEMOTHERAPEUTIC-AGENTS U-73,975, U-77,779, AND U-80,244 IN GYNECOLOGIC CANCER CELL-LINES
Authors: HIGHTOWER RD SEVIN BU PERRAS J NGUYEN H ANGIOLI R UNTCH M AVERETTE H
Citation: Rd. Hightower et al., INVITRO EVALUATION OF THE NOVEL CHEMOTHERAPEUTIC-AGENTS U-73,975, U-77,779, AND U-80,244 IN GYNECOLOGIC CANCER CELL-LINES, Cancer investigation, 11(3), 1993, pp. 276-282
CONTRAST-ENHANCED MRI OF THE BREAST AFTER LIMITED SURGERY AND RADIATION-THERAPY
Authors: HEYWANGKOBRUNNER SH SCHLEGEL A BECK R WENDT T KELLNER W LOMMATZSCH B UNTCH M NATHRATH WBJ
Citation: Sh. Heywangkobrunner et al., CONTRAST-ENHANCED MRI OF THE BREAST AFTER LIMITED SURGERY AND RADIATION-THERAPY, Journal of computer assisted tomography, 17(6), 1993, pp. 891-900
CHARACTERISTICS OF THE COMBINATION PACLITAXEL PLUS DOXORUBICIN IN BREAST-CANCER CELL-LINES ANALYZED WITH THE ATP-CELL VIABILITY ASSAY
Authors: KOECHLI OR SEVIN BU PERRAS JP CHOU TC ANGIOLI R STEREN A UNTCH M AVERETTE HE
Citation: Or. Koechli et al., CHARACTERISTICS OF THE COMBINATION PACLITAXEL PLUS DOXORUBICIN IN BREAST-CANCER CELL-LINES ANALYZED WITH THE ATP-CELL VIABILITY ASSAY, Breast cancer research and treatment, 28(1), 1993, pp. 21-27
VAGINAL ADENOCARCINOMA AND ADENOSIS - HISTOGENESIS, DIAGNOSIS AND THERAPY OF A RARE DISEASE
Authors: MAASSEN V LAMPE B UNTCH M MIKOREY S HEPP H KINDERMANN G
Citation: V. Maassen et al., VAGINAL ADENOCARCINOMA AND ADENOSIS - HISTOGENESIS, DIAGNOSIS AND THERAPY OF A RARE DISEASE, Geburtshilfe und Frauenheilkunde, 53(5), 1993, pp. 308-313
ENHANCEMENT OF PROGESTERONE-RECEPTOR LEVELS BY INTERFERONS IN AE-7 ENDOMETRIAL CANCER-CELLS
Authors: ANGIOLI R UNTCH M SEVIN BU STEREN A HIGHTOWER RD PERRAS JP NGUYEN HN KOECHLI OR AVERETTE HE
Citation: R. Angioli et al., ENHANCEMENT OF PROGESTERONE-RECEPTOR LEVELS BY INTERFERONS IN AE-7 ENDOMETRIAL CANCER-CELLS, Cancer, 71(9), 1993, pp. 2776-2781
INVITRO POTENTIATION OF RADIATION CYTOTOXICITY BY RECOMBINANT INTERFERONS IN CERVICAL-CANCER CELL-LINES
Authors: ANGIOLI R SEVIN BU PERRAS JP UNTCH M KOECHLI OR NGUYEN HN STEREN A SCHWADE JG VILLANI C AVERETTE HE
Citation: R. Angioli et al., INVITRO POTENTIATION OF RADIATION CYTOTOXICITY BY RECOMBINANT INTERFERONS IN CERVICAL-CANCER CELL-LINES, Cancer, 71(11), 1993, pp. 3717-3725
Risultati: 1-25 | 26-50 |